🇺🇸 FDA

Intelligence · Clinical Pipeline

Sinovac Research and Pipeline

All ClinicalTrials.gov programs at Sinovac Research and — phase, modality, and trial IDs.

Programs
47

Quick answer

Sinovac Research and has 47 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 2 doses of HAV

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  2. 2012-2013 trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  3. 2wIPV+1sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    1 trial

  4. 5000 volunteers (6-35 months)-EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  5. Adult group in immunogenicity and safety study of combined immunization

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  6. COVID-19 Vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  7. Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine

    Sinovac Research and Development Co.,

    Influenza and Pneumonia

    approved mab completed

    1 trial

  8. Concomitant administration of EV71 vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  9. Concomitant administration of EV71vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  10. EV71 Vaccine

    Sinovac Research and Development Co.,

    EV71 Vaccine

    approved mab completed

    1 trial

  11. EV71 inactived vaccine（Vero cells）

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  12. EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  13. Experimental 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  14. Experimental 23-valent Pneumococcal

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  15. Experimental Group

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    4 trials

  16. Experimental Vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial

  17. Experimental vaccine 1

    Sinovac Research and Development Co.,

    COVID-19

    approved mab on hold

    1 trial

  18. H1N1 influenza A Vaccine (PANFLU.1)

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  19. H1N1 influenza A Vaccine (Split virion), Inactivated

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  20. Healive (hepatitis A vacine(human diploid cell), inactivated)

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab active

    1 trial

  21. Healive+Healive

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  22. Healive® Lot 1

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  23. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  24. High-dosage of COVID-19 vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  25. Inactivated HAV vaccine

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  26. Inactivated Hepatitis A vaccine (HAV)

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  27. Inactivated SARS-CoV-2 Vaccine (Vero cell) Lot 1 of the workshop 2

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  28. Inactivated SARS-CoV-2 Vaccine (Vero cell）

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  29. Investigational 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    2 trials

  30. Investigational live attenuated varicella vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab active

    4 trials

  31. Live attenuated varicella vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab active

    3 trials

  32. Mumps vaccine

    Sinovac Research and Development Co.,

    Mumps

    approved mab completed

    1 trial

  33. Mumps vaccine, Live (MV)

    Sinovac Research and Development Co.,

    Mumps

    approved mab active

    1 trial

  34. Pandemic influenza A/H1N1 vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  35. Quadrivalent Influenza Vaccine (Split Virion), inactivated

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial

  36. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials

  37. The live attenuated varicella vaccine and the inactivated hepatitis A vaccine

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial

  38. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  39. Two doses of quadrivalent influenza vaccine

    Sinovac Research and Development Co.,

    Seasonal Influenza

    approved mab completed

    1 trial

  40. Vaicella Vaccine+DTaP on Day 0, MMR on Day 30

    Sinovac Research and Development Co.,

    Varicella (chickenpox)

    approved mab active

    1 trial

  41. Varicella vaccine

    Sinovac Research and Development Co.,

    VZV

    approved mab completed

    1 trial

  42. Varicella vaccine+TIV

    Sinovac Research and Development Co.,

    Varicella

    approved mab completed

    1 trial

  43. sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    3 trials

  44. sIPV vaccine /DTaP vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab completed

    1 trial

  45. seasonal split influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  46. split-virion, adjuvanted H1N1 vaccine of 7.5 μg per dose

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  47. trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

Frequently asked questions

How many pipeline programs does Sinovac Research and have?

47 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.